Evaluation of safety and efficacy of ZD1839 as monotherapy for Chinese patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Zhang, XT [1 ]
Li, L [1 ]
机构：
[1] CAMS, Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7093
引用
收藏
页码：639S / 639S
页数：1
相关论文
共 50 条
  • [1] Evaluation of efficacy and safety of ZD1839 as monotherapy for Chinese patients with advanced non-small cell lung cancer: Experience from a compassionate-use programme.
    Wang, MZ
    Li, LY
    Wang, SL
    Zhang, XT
    Zhong, W
    Zhang, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 683S - 683S
  • [2] ZD1839 for the treatment of heavily pretreated non-small cell lung cancer.
    Wu, YL
    Yang, X
    Yang, JJ
    Huang, YJ
    Chen, G
    Gu, LJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 701S - 701S
  • [3] ZD1839 (Iressa™) in non-small cell lung cancer
    Herbst, RS
    Kies, MS
    ONCOLOGIST, 2002, 7 : 9 - 15
  • [4] Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer
    Park, J
    Park, BB
    Kim, JY
    Lee, SH
    Lee, SI
    Kim, HY
    Kim, JH
    Park, SH
    Lee, KE
    Park, JO
    Kim, K
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Lee, MH
    Park, K
    CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4383 - 4388
  • [5] Evaluation of safety and efficacy of erlotinib as monotherapy for Chinese patients with advanced non-small cell lung cancer
    Zhang, Xiao-Tong
    Li, Long-Yun
    Wang, Meng-Zhao
    Zhang, Li
    Zhong, Wei
    Wang, Shu-Lan
    ANNALS OF ONCOLOGY, 2007, 18 : 184 - 185
  • [6] Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme
    Mu, XL
    Li, LY
    Zhang, XT
    Wang, SL
    Wang, MZ
    BMC CANCER, 2004, 4 (1)
  • [7] Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme
    Xin-Lin Mu
    Long-Yun Li
    Xiao-Tong Zhang
    Shu-Lan Wang
    Meng-Zhao Wang
    BMC Cancer, 4
  • [8] Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients
    Herbst, RS
    SEMINARS IN ONCOLOGY, 2003, 30 (01) : 30 - 38
  • [9] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Meng-zhao
    中华医学杂志(英文版), 2006, (01) : 63 - 68
  • [10] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Mengzhao LI Longyun WANG Shulan ZHANG Xiaotong ZHONG Wei and ZHANG LiDepartment of Respiratory Diseases Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China
    Chinese Medical Journal, 2006, (01) : 63 - 68
12345